|
NEWS, EVENTS, and DEADLINES
August 7, 2023
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
Find out what impact your research or innovation could have in solving real-world problems by attending the next Novus I-Corps program, a half-day introduction to I-Corps followed by optional self-paced coursework, at the New Jersey Institute of Technology (NJIT). | |
NCATS, NIH, and Federal News and Events | |
Preparing the Future Workforce in Drug Research & Development: A Workshop
The National Academies Forum on Drug Discovery, Development, and Translation will host a public workshop for stakeholders to consider what is needed to support the next generation workforce – one that is resilient, culturally aware, and interdisciplinary. Workshop participants will identify the types of expertise and disciplines needed to achieve the aspirations for a transformed clinical trials enterprise in 2030 and enable a workforce that can better support the evolving needs of drug discovery, development, and translation.
| |
|
October 16-17, 2023
Location:
National Academy of Sciences Building
2101 Constitution Ave NW
Washington DC 20418
| |
|
Register to attend
Online or In Person
| | |
|
Collaboration Webinars from the Trial Innovation Network
Hear from CTSA TIN experts on various trial-related topics to improve your project.
| |
|
Single IRB Unlocked: IREx is the Key to Efficient Single IRB Review for Lead Study Teams
How the IREx platform can be key to efficient sIRB review for lead study teams.
September 20, 2023
12 pm
| |
A Community Engaged Approach to Recruitment and Retention of Underrepresented Populations in Research
Effective strategies for investigators and others who work in and with diverse communities to develop greater capacity and success in engaging, recruiting, and retaining research participants from underrepresented populations.
October 2, 2023
12 pm
| |
|
Expanding patient access to research opportunities through novel approaches: An institution’s implementation of an opt-out, cold-contact recruitment process and methods to improve the feasibility and rigor of remote trials
The Medical University of South Carolina’s adoption and implementation of an opt-out, cold-contact patient recruitment policy (referred to as Patient Outreach Recruitment) allowing researchers to reach out to potentially eligible study subjects identified via the electronic health record.
October 18, 2023
12 pm
|
|
|
Biomarkers Core promotes and supports non-oncological translational research by Rutgers investigators and their collaborators.
Our team of experts in molecular and cellular biology and in immunology helps identify state-of-the-art approaches to tackle research questions in infectious and non-infectious diseases. The core’s services span assistance in experimental design and project development, scientific collaboration and consultation.
| Please email request forms to Natalie Bruiners. | |
Watch a video about the Biomarker Core | |
|
Generational Shifts in Young Adult Cardiovascular Health? Millennials and Generation X in the United States and England. Martinson ML, Lapham J, Ercin-Swearinger H, Teitler JO, Reichman NE. J Gerontol B Psychol Sci Soc Sci. 2022 May 27;77(Supplement_2):S177-S188. PMID: 35195713 PMCID: PMC9154229 DOI: 10.1093/geronb/gbac036
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic. Nguyen T, Ziedan E, Simon K, Miles J, Crystal S, Samples H, Gupta S. JAMA Network Open. 2022 Jun 1;5(6):e2214765.
PMID: 35648400 PMCID: PMC9161014 DOI: 10.1001/jamanetworkopen.2022.14765
| |
NIH Diversity Funding Opportunity - Research Supplements to Promote Diversity in Health-Related Research (Admin Supplement - Clinical Trial Not Allowed) - PA-23-189 | |
The National Institutes of Health's All of Us Research Program has expanded its data to include nearly a quarter million whole genome sequences for broad research use. Read more! | |
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP), funded by Congressionally Directed Medical Research Programs, has a September 28, 2023 deadline for the Clinical Trial Award ($500K - $4.0M) and the Focused Program Award ($5.0M). See Flyer for Details | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health. | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
| | | | |
